Cardiologist Nakela Cook to Lead PCORI
The Patient-Centered Outcomes Research Institute (PCORI) has tapped cardiologist Nakela Cook to lead the organization as its next executive director, [...]
CVS, Cigna Talk M&A, Election Year
CVS and Cigna executives during the annual J.P. Morgan Healthcare Conference discussed consolidation in the insurance sector and the upcoming [...]
Lansky Mulls Medicare for All’s Implications on Value
David Lansky, former CEO of the Pacific Business Group on Health, in a recent Health Affairs blog post considers whether [...]
With $200M in Funding, Pharma Startup Wants to Bring New Drugs in ‘Sustainable Method’
With $200 million in startup funding, a new Massachusetts-based drug company called EQRx is looking to shake up the pharmaceutical [...]
Award-winning Journalist Buettner to Open AMCP 2020 General Session
The Academy of Managed Care Pharmacy (AMCP) announced Dan Buettner, award-winning journalist and producer, as the opening general session speaker [...]
Parexel’s New Organization Aims to Bolster Clinical Development
In a bid to optimize clinical development, Parexel has launched its new Regulatory & Access consulting organization consisting of more [...]
Report Spotlights RWE in Medical Affairs
A recent report by FirstWord Pharma looks at how real-world evidence is performing in the medical affairs landscape. The report [...]
ICMJE’s Updated Recommendations Include Increased Emphasis on Transparency
The International Committee of Medical Journal Editors (ICMJE) in December updated its "Recommendations for the Conduct, Reporting, Editing and Publication [...]
Study’s Results a Blow to Popular Idea for Lower Health Costs
A popular idea that investing more resources into caring for the sickest and costliest patients could help cut health costs [...]
Providers’ ‘Deeply Ingrained’ Model Disrupts Shift to Value
While providers claim a number of reasons for their reluctance to shift to risk-based deals, Numerof & Associates' Rita Numerof [...]
Report: Denmark Adopting QALY in Cost-Effectiveness Assessments
Beginning in October, the Danish Medicines Council will use the quality-adjusted life year (QALY) metric in its cost-effectiveness assessments, The [...]
Blog Post: Patient Influencers’ Company Ties Should be Public
The authors of a recent Health Affairs blog post say patients and patient organizations with ties to industry and industry [...]
ICER Releases Final Report on JAK Inhibitors for RA
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 9, released its final report on JAK inhibitors for [...]
Article: Don’t Let QALY Restrict Life-Saving Drugs
Gunnar Esiason, an MBA/MPH candidate at the Dartmouth Tuck School of Business, in a recent article published on The Hill [...]
Blog Post Spotlights State of Low-Value Care Research
The Research Community on Low-Value Care, a joint initiative of AcademyHealth, the ABIM Foundation, and the Donaghue Foundation, is working [...]
NPC: No ‘Best’ Framework for Value Assessment
The National Pharmaceutical Council (NPC) in a recent report found that out of seven value assessment frameworks, there was no [...]
Google Offering FDA’s MyStudies Platform on Cloud Service
Google Cloud announced this week it would support the Food and Drug Administration's (FDA) mission by offering the agency's MyStudies [...]
Researchers Find Decades-Old Ingredients in Costly Drugs
A team of Harvard Medical School researchers in a new study suggest that 11 of the 27 active ingredients in [...]
ISPOR Publishes Report Top 10 HEOR Trends
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) this week published its 2020 Top 10 HEOR Trends report. "As [...]
Article Highlights CanREValue Collaboration for RWE
A recent article published in BMJ highlights efforts by the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration, [...]
Alexion Pharmaceuticals Braces for Major Competitor
While Alexion Pharmaceuticals' blockbuster drug Soliris netted more than $3 billion for the company last year, the drug could face [...]
ISPOR Webinar to Spotlight Task Force Guidelines
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar at 10:30 a.m. EST Jan. [...]
Researchers Find ICER Makes ‘Modest’ Revisions Based on Comments
Tufts Medical Center researchers in a recent article published in Value in Health found that the Institute for Clinical and [...]
ICER Outlines Planned Review for Beta Thalassemia Treatments
The Institute for Clinical and Economic Review (ICER) on Monday released a new document outlining a planned review of LentiGlobin [...]
Health Analyst: U.S. Health System Deeply Flawed
While the U.S. health care system is "admirable" in a number of ways, including key innovations in medicines and procedures, [...]